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Urinary bladder malformations associated with bladder outlet obstruction are a frequent cause of progressive renal failure in children.
We here describe a muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous frameshift mutation in familial congenital
bladder malformation associated with a prune-belly-like syndrome, defining an isolated gene defect underlying this sometimes devas-
tating disease. CHRM3 encodes the M3 muscarinic acetylcholine receptor, which we show is present in developing renal epithelia and
bladder muscle. These observations may imply that M3 has a role beyond its known contribution to detrusor contractions. This Mende-
lian disease caused by a muscarinic acetylcholine receptor mutation strikingly phenocopies Chrm3 null mutant mice.Lower urinary tract and/or kidney malformations account
for 40% of childhood end-stage renal failure.1 Advances
have been made in unraveling the genetic pathogenesis
of kidney anomalies,2 but less is known about the genetic
origin of malformations of the lower tract. Congenital
bladder outflow obstruction (BOO) has several causes, the
commonest being posterior urethral valves (PUVs), with
a high risk of developing chronic renal insufficiency.1,3
Recently, mutations of HPSE2 (MIM 613469; see Web
Resources), encoding a heparanase inhibitor expressed in
developing urinary tracts, were described in urofacial
syndrome (UFS [MIM 236730]), which presents with
a dysmorphic, poorly emptying bladder.4 Also associated
with congenital bladder dysfunction is prune belly
syndrome (PBS [MIM 100100]). In its rare complete form,
it comprises megacystis with disorganized detrusormuscle,
cryptorchidism and thin abdominal musculature with
overlying lax skin. PUV and PBS generally occur sporadi-
cally, although families have been reported with more
than one affected member.3,5,6
We here describe a homozygous loss-of-function muta-
tion of muscarinic acetylcholine receptor M3 (CHRM3)
(1q41-q44) in five brothers with a PBS-like syndrome
(Figures 1 and 2). CHRM3 (MIM 118494) encodes the M3
subtype of muscarinic acetylcholine (ACh) receptors, the
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20055 when there were four surviving boys with congen-
ital BOO born to consanguineous Turkish parents. A fifth
affected male sibling had died soon after birth as a result
of renal failure and urosepsis (II-1). He and one affected
surviving brother (II-4) displayed marked abdominal wall
distension and were assigned as having PBS, whereas their
three brothers were considered to have ‘‘PUV’’ because
cystopscopy noted urethral valve-like structures. Recently,
a sixth brother (II-7) was born, also with a malformed
bladder. Evaluation of available cystograms showed
massive and irregular-walled bladders with diverticulae
(Figure 1). Vesicoureteric reflux was a variable feature.
Urethral patency appeared normal in available cystograms.
Cystometry performed in four affected boys in the first
years of life revealed detrusor hyporeflexia with high
residual volumes after micturition. Thus, the collective
features in this kindred are most consistent with the PBS
spectrum. Affected individuals also had bilaterally
impaired pupillary constriction to light (Figure 1) and dry
mouths. These examinations were performed after
informed consent was obtained from the patients and their
parents. Ethical approval for this study was obtained from
the ethics review board at the Ruprecht-Karls-University
Heidelberg and the collaborating institutions, according
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Figure 1. Clinical Features in Family with CHRM3Mutation
(A) Cystogram of individual II-7 demonstrating a massively enlarged bladder.
(B) Cystogram of index person II-4 showing an irregular-walled bladder with diverticula (black arrows) and unilateral high-grade vesi-
coureteral reflux into a distorted renal pelvis (white arrow).
(C) Abdominal wall laxicity of index person II-4.
(D) Impaired pupillary constriction to bright light in index person II-4.Using a SNP chip-based genome-wide linkage approach,
we previously identified two regions of homozygosity on
chromosomes 1 (35 cM) and 11 (9 cM) in four affected
surviving males of this family (Figure 2).5 Exon capture
and massively parallel sequencing now lead to the identifi-
cation of the causative genetic defect in CHRM3, located in
the chromosome 1 critical interval (Figure 2). DNA of
index patient II-4 was enriched for protein-coding genes
with the Agilent SureSelect Human All Exon 38 Mb kit
and ran on two lanes of the Illumina GAIIx Sequencer
with the paired-end protocol and a read length of 95 bp
at each end, generating ~202 3 106 raw reads of which
~193 3 106 could be mapped to the human reference
sequence. Alignment and variant calling was performed
with MAQ for SNP detection (version 0.7.1)8 and BWA-
short (version 0.5.7)9 in combination with SAMTOOLS
(version 0.1.7)10 for indel detection. On average, 90% of
the exome was covered at least 30-fold and 97% ten-fold.
Scripts developed in-house were applied to detect protein
changes, affected splice sites, and overlaps with known
variants (Table S1 available online). In detail, using MAQ
and SAMtools, we identified a total of 672,588 variations.
After filtering for a minimal phred-like consensus qualityThe Americanscore > 15, 517303 variations remained. A stringent filter
step discarding known variations with dbSNP, 1,000
genomes data, and the CCG in-house database with ~100
exomes reduced the list to 48811. Further filtering for
homozygosity (allele frequency > 75%) together with
changes in protein sequence or location 525 nts inside
30/50 splice sites reduced the list to 38 candidate variations.
Finally, only two variations were found to overlap with the
previously identified regions of significant linkage—
a missense change in HEATR1:c.6037A > G;p.Lys2013Glu
(RefSeq accession number NM_018072.5) and an inser-
tion-deletion frameshift mutation in CHRM3:
c.1173_1184 delinsT; p.Pro392Alafs*43 (RefSeq accession
number NM_000740.2). Both variations were not present
at the Exome Variant Server, NHLBI Exome Sequencing
Project (ESP, Seattle, WA; see Web Resources). HEATR1
encodes BAP28, a protein involved in rRNA transcription
and processing, and knockdown of Heatr1 in zebrafish
causes embryonic death due to CNS degeneration,11
a phenotype considerably different from the one observed
in our index patient. CHRM3, however, encodes the
human muscarinic acetylcholine receptor M3 (hereafter
simply calledM3), a G protein-coupled receptor with sevenJournal of Human Genetics 89, 668–674, November 11, 2011 669
Figure 2. Deletion-Insertion Mutation of CHRM3
(A) Family pedigree. The index person II-4 and a deceased boy (II-1) presented with the full picture of PBS. Their male siblings, II-2, II-5,
II-6, and II-7, had malformed bladders only. Chronic kidney disease (CKD) grade II was observed in affecteds II-5 and II-6, CKD grade IV
in index person II-4.
(B) p.Pro392Alafs*43 introduces a premature termination codon in the third intracellular loop (M3R) resulting in a truncated protein
that lacks the last two transmembrane domains (shown in red).
(C) A homozygous CHRM3 frameshift mutation c.1173_1184 delinsT;p.Pro392Alafs*43 was identified in index person II-4 by massively
parallel sequencing; five forward (upper case) and three reverse reads (lower case) were recognized as an insertion-deletion mutation.
(D and E) Three-dimensional protein structure modeling of wild-type (D) and mutant (E) receptor M3. Transmembrane helices (I-VII)
and the amino- (N) and carboxy- (C) termini are indicated. Structure predictions of mutantM3 suggest complete deterioration of folding
of the third intracellular loop (M3R) in addition to loss of transmembrane helices VI and VII in mutant M3. Three-dimensional protein
structure modeling was obtained as a homology (comparative) protein structure with (PS)2-v2 using Protein Data Bank (PDB) entries
2rh1, 2rh1A and 1r5sA as template.31 Structures were processed with Jmol. Model reliability is R75% for wild-type and mutant
(excluding the mutant C terminus) and 55%–75% for the mutant C terminus.transmembrane domains and the major receptor involved
in mediating urinary bladder contraction upon micturi-
tion.7 Both the obvious loss-of-function nature of the
CHRM3mutation and the striking similarity of the human
phenotype to Chrm3 null mutant mice (discussed below)
underscored the likelihood of this mutation being the
causal genetic lesion in our family. The p.Pro392Alafs*43
mutation induces a premature termination codon (PTC)
at position 435. If mutant RNA transcripts were stable
and translated, a truncated M3 protein would be generated
lacking part of the third cytosolic loop, transmembrane670 The American Journal of Human Genetics 89, 668–674, Novembdomains VI and VII and the C terminus of the receptor.
Three-dimensional structure predictions of mutant M3
suggest perturbed folding of the remaining third intracel-
lular loop (Figure 2), known to be essential for signal trans-
duction through G protein activation and scaffold protein
interaction.12 Sanger sequencing was performed for
individuals II-2, II-3, II-4, II-5, II-6, II-7, I-1, and I-2 of the
family. The c.1173_1184 delinsT; p.Pro392Alafs*43 muta-
tion of CHRM3 cosegregated consistently with the disease
phenotype according to a recessive mode of inheritance5
and was absent from 374 Turkish control chromosomeser 11, 2011
(power >95% to distinguish a normal sequence variant
given an allele frequency of 0.0113). The mutation was
also not annotated in the Exome Variant Server SNP data-
base. All affected males were shown to be homozygous for
the CHRM3 mutation whereas both parents and the unaf-
fected sister (II-3) were heterozygous carriers. CHRM3
mutations and homozygous deletions were not identified
by Sanger sequencing in five multiplex PUV families, 38
simplex PUV cases, 19 simplex PBS cases, four simplex
megacystis cases, three unrelated individuals affected by
UFS lacking HPSE2mutations,4 and a cohort of 86 individ-
uals of the 4C-Kidney Disease Study with bladder and/or
urethral anomalies (see Web Resources). Because of the
recessive nature of the disease, we did not look for hetero-
zygous deletions in this cohort.
Notably, Pomper et al.14 recently reported an adult with
micturition failure since childhood and with pupils that
failed to constrict upon muscarinic stimulation. This
phenotype is strikingly similar to that affecting the family
in our current report. An absence of M3 protein was found
in bladder tissue and a CHRM3 mutation was postulated.
However, sequencing and copy number analyses were
normal in the individual presented by Pomper et al., consis-
tent with a yet-to-be-defined genetic or acquired disorder
affecting generation of M3 protein and/or its stability.
To date, human mutations of nicotinic acetylcholine
receptor subunits have been described, e.g., in the fetal
akinesia deformation sequence (MIM 208150) where
they seem to be involved in morphogenetic signal trans-
duction in addition to skeletal muscle contraction.15 Our
report describes a Mendelian human disease caused by
a muscarinic acetylcholine receptor mutation, linking
a developmental disorder of the renal tract to a component
of the parasympathetic nervous system. Key functions of
the bladder are to act as a low-pressure reservoir for urine
and to expel urine per urethra. The latter is driven by detru-
sor contractions stimulated by parasympathetic nerves.
Although male and female adult human bladders express
mRNA of two muscarinic acetylcholine receptor subtypes
(M2 and M3),16,17 only M3 is the critical receptor for
micturition,7 mediating 95% of cholinergic contraction
of the detrusor muscle.18 In mice and rats, M3 is observed
in bladders of both young animals and adults.19,20
For determining the localization of M3 in embryonic
and fetal tissue, immunohistochemistry studies were per-
formed with M3 antibodies in wild-type mice and human
embryos (Figure 3).21 The latter were collected with
informed consent under Polkinghorne Committee guide-
lines and staged by the Carnegie classification or foot
length. In embryonic day 13 mice, M3 was present in
nascent bladder and urethral epithelia. Later in mouse
gestation, when the bladder becomes muscularized, M3
was immunodetected in bladder urothelial and detrusor
muscle layers. M3 was also localized in ureteric and meta-
nephric kidney nephron precursors. In normal human
embryos, M3 protein was detected in urogenital sinus
and urethral epithelia and in the late first trimester bladderThe Americanin urothelia and muscle cells. M3 protein is therefore not
only present in fetal bladder muscle but also in the urogen-
ital sinus and fetal urethral epithelia, concurring with sites
of embryonic Chrm3 mRNA expression according to
Mouse Genome Informatics and GUDMAP databases (see
Web Resources). GUDMAP also reports Chrm3 transcripts
in the metanephros, and we detected M3 protein in
nephron precursors. Collectively, these observations may
imply that M3 has a role beyond its known contribution
to detrusor contractions. Preliminary GUDMAP data exists
that ChAT transcripts are expressed in embryonic kidneys
as well as in embryonic bladder and urethral mesenchyme.
If the encoded protein, choline acetyltransferase (ACh), is
also detectable, non-neuronal ACh may be synthesized
in the nascent renal tract. In future studies, it will be inter-
esting to address the possibility that ACh is also expressed
in non-neuronal tissues.
In homozygous Chrm3 mutant mice lacking M3, adult
detrusor contractility to carbachol ex vivo is impaired
and (only) male mutant adult bladders are grossly dis-
tended in vivo.18 Although it is unknown whether mega-
cystis is present in younger Chrm3mutant mice, the hypo-
contractile bladder phenotype is very similar to humans
with CHRM3 mutations, described above. Of note, only
male Chrm3 mice will develop clinical disease. This is, at
least in mice most probably, related to differences between
male and female urethral anatomy with male bladders
being more contractile to force the urine through the
longer urethra. Alternatively, female mice (but not males)
might have other compensatory physiological mecha-
nisms allowing them to empty their bladders independent
of M3 action. Expression and function of M3 in rat and
guinea pig urinary bladders do not seem to differ consider-
ably between male and female animals22 and with regard
to overall muscarinic responsiveness this situation appears
to be similar in humans.23 In humans, we can neither rule
out nor confirm a male-limited phenotype: the pedigree of
the presented index family is not helpful to delineate the
phenotype of female homozygous CHRM3 mutation
carriers given that no female individual is affected by
such a mutation. Mother and sister of the index person
are both heterozygous mutation carriers with apparently
normal bladder anatomy and function. With respect to
PBS, the full clinical picture, including BOO, cryptorchi-
dism, and abdominal wall distension, is limited to males;
however, incomplete forms of PBS have also been
described in females.24,25
The etiology of abdominal muscle deficiency in individ-
uals with PBS has been a matter of controversy. Either
a common underlying defect of mesodermal development
is proposed25 or, as other authors suggest, abdominal
muscle deficiency seems to be a nonspecific anatomic
defect that is secondary to fetal abdominal wall distention
(caused by megacystis, hydronephrosis or constipation).26
In the present study, RT-PCR experiments were performed
on RNA extracted from human mature abdominal wall
musculature, but no M3 expression was apparentJournal of Human Genetics 89, 668–674, November 11, 2011 671
Figure 3. M3 Localization in the Developing
Renal Tract
Immunohistochemistry of M3 on sections of
normal mouse (A–E) and human (F–I) embryos
by respectively applying M3 antibodies Sigma
M0194 and Abcam 60981.
(A and B) Embryonic day 13 sagittal sections.
(A) Localization of M3 in epithelia of the urogen-
ital sinus, which has separated from the hindgut
(hg); the upper (cranial) part of the sinus is form-
ing the bladder (bl) and the lower part of the
sinus is forming the urethra (u) extending into
the genital tubercule (gt). M3 is also detected in
hindgut epithelia. The spine (sp) is dorsal to the
hindgut.
(B) Adjacent section with primary antibody
omitted.
(C) Embryonic day 15 bladder. M3 localization in
detrusor smooth muscle (dsm) as well as urothe-
lia; the asterisk indicates lumen.
(D) Longitudinal section through embryonic day
14 ureter, when urothelium is surrounded by
mesenchyme which has yet to form muscle;
M3 is localized in epithelia.
(E) Forming nephron in embryonic day 13 meta-
nephric kidney. The upper part is the precursor of
the glomerulus (g) while the lower section will
form the tubule (t); in both M3 is detectable.
(F) Sagittal section at 51 days post conception
when the urogenital sinus (ugs) and hindgut
(hg) terminate in a common cloaca (c). M3 is
localized to both urogenital sinus and hindgut
epithelia.
(G) Transverse section through the urethra at the
bladder outlet (10 weeks after conception); M3
localization to urothelia while the surrounding
mesenchyme (m) is negative is shown.
(H) Bladder wall 12 weeks after conception; M3
detection in human detrusor smooth muscle
(dsm; indicated by arrows) and urothelia; the
asterisk indicates lumen.
(I) Adjacent section with primary antibody
omitted. Scale bars represent 500 mm (A and B),
100 mm (C), 125 mm (D), 50 mm (E), 200 mm (F),
100 mm (G), and 400 mm (H and I).(Figure S1). These data are in favor of abdominal wall
distension being a secondary event after megacystis and/
or urinary stasis due to impaired urinary bladder contrac-
tion early in fetal life.
Failure of bladder contractility before birth in humans
with homozygous (or compound heterozygous) CHRM3
mutation might contribute to the observed bladder
dysmorphology postpartum. Bladder dysfunction is likely
to persist in individuals with CHRM3mutation thoughout
life, constituting an important risk factor for the progres-
sion of renal insufficiency.3 Chrm3 mutant mice also
display impaired salivation and dilated pupils, consis-
tent with a role for muscarinic ACh actions in serous
salivary secretion and pupillary constriction,18 and
a similar phenotype is present when human CHRM3 is
mutated.672 The American Journal of Human Genetics 89, 668–674, NovembDeletions within 17q12 encompassing hepatocyte nuclear
factor 1B (HNF1B [MIM 189907]) have been reported in
sporadic PBS,27 but whether HNF1B itself or a nearby dis-
rupted gene is causative remains unclear, and HNF1B
mutations have not yet been implicated in familial PBS.
Furthermore, although HNF1B mutations are a not
uncommon cause of dysplastic kidneys,2,28 such patients
rarely have overt bladder lesions. Importantly, in our
CHRM3 mutation family, HNF1B was normal by
sequencing and seeking copy number variants (data not
shown). Mice mutant for b2 and b4 or a3 subunits of the
nicotinic ACh receptor29,30 display enlarged, hypocontrac-
tile bladders, as a result of compromised neural relaying via
autonomic ganglia, and may serve as models for humans
with congenital BOO who do not have CHRM3, HPSE2,
or HNF1B mutations. We suggest that the next decadeer 11, 2011
will witness the unraveling of genetic causes of bladder
malformations, thus providing insights into the mecha-
nisms of both normal development and explaining how
bladder dysmorphology arises in the context of PBS, PUV,
UFS and other related syndromes.3Supplemental Data
Supplemental Data include one table and one figure and can be
found with this article online at http://cell.com/AJHG/.Acknowledgments
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